NCT02679469View on ClinicalTrials.gov

A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Alcohol Dependence
Interventions
DRUG

nalmefene hydrochloride 10 mg

Trial Locations (1)

Unknown

Kyusyu, Region

Sponsors
All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY